Ustekinumab‑Srlf Suppliers & Bulk Manufacturers

Available Forms: Subcutaneous injection, Intravenous infusion

Available Strengths: 45 mg or 90 mg doses

Reference Brands: Stelara(US & EU); Imuldosa (ustekinumab-srlf) is a biosimilar of Stelara

Category: Biosimilars

Ustekinumab‑srlf is available in Subcutaneous injection, Intravenous infusion and strengths such as 45 mg or 90 mg doses. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ustekinumab‑srlf is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ustekinumab‑srlf can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Ustekinumab (Ustekinumab-srlf) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, FDA approval involves extensive clinical validation and safety assessments. In the EU, CE marking certifies conformity with MDR standards. These products undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective biologic therapies worldwide, supporting optimal management of psoriasis, psoriatic arthritis, and Crohn’s disease.